IDEAS home Printed from https://ideas.repec.org/a/bla/jorssc/v68y2019i2p475-491.html
   My bibliography  Save this article

Treatment and dose prioritization in early phase platform trials of targeted cancer therapies

Author

Listed:
  • Yimei Li
  • Ming Wang
  • Ying Kuen Cheung

Abstract

With the advances in the discovery of molecular targets, there is increasing interest in evaluating targeted therapies for disease subtypes characterized by certain biomarkers. Patients with a certain biomarker could potentially benefit from different experimental drugs, and, therefore, evaluating the relative efficacy of these drugs is an important objective. We consider the design of an early phase platform trial where multiple therapies are evaluated in patients with different biomarkers, with the objective of identifing the best drug at an efficacious and safe dose for a given disease subtype. We use the continual reassessment method to estimate the maximum tolerated dose of a drug and adopt hierarchical Bayesian modelling to estimate the efficacy of a drug administered at multiple doses. Using the continual reassessment method and hierarchical Bayesian modelling as the basis of inference, we propose various algorithms that prescribe the drug–dose for the patients using adaptive randomization. We demonstrate that adaptive randomization puts more patients at the right drug and dose on average than does balanced randomization, with slightly larger variability in distribution, and has no effect on the accuracy of drug–dose selection. Moreover the simulations show advantages of hierarchical Bayesian modelling over the beta–binomial model in scenarios with relatively flat or partially flat dose–efficacy relationships.

Suggested Citation

  • Yimei Li & Ming Wang & Ying Kuen Cheung, 2019. "Treatment and dose prioritization in early phase platform trials of targeted cancer therapies," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 68(2), pages 475-491, February.
  • Handle: RePEc:bla:jorssc:v:68:y:2019:i:2:p:475-491
    DOI: 10.1111/rssc.12324
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/rssc.12324
    Download Restriction: no

    File URL: https://libkey.io/10.1111/rssc.12324?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:jorssc:v:68:y:2019:i:2:p:475-491. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://edirc.repec.org/data/rssssea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.